Pharma Marketing Network

The rise of biosimilars is no longer a distant trend. It is happening now, reshaping how pharmaceutical brands compete and communicate. As regulatory changes...

As pricing transparency laws reshape the healthcare landscape, pharma marketing strategies around PBM reform are becoming a central concern for pharmaceutical marketers. Have you...

As pharmaceutical growth slows across the United States, Europe, and Japan, companies are increasingly turning their attention toward developing healthcare systems. Markets across Asia,...

The way patients discover healthcare is changing quickly. Instead of starting with a doctor’s office or pharmacy counter, many people now begin with platforms...

Pharmaceutical marketers face a measurement dilemma. Traditional attribution models often promise clear answers, yet the reality of modern engagement is far more complex. Physicians...

What if your next drug launch isn’t judged first by physicians, but by algorithms? That shift is already happening. Today, an effective AI pharma...

Prescribing decisions rarely happen in a purely rational way. Even though clinical evidence plays a central role, physicians often rely on mental shortcuts, experience,...

Pharmaceutical brands no longer compete only on product performance. Instead, many now compete to shape the broader conversation around disease understanding and patient education....

Real-world data is everywhere in healthcare today. Hospitals collect outcomes data, patient registries track long-term treatment results, and insurers analyze therapy effectiveness at scale....

Pharmaceutical companies have traditionally focused on developing and marketing therapies. However, healthcare systems now face challenges that demand broader collaboration. Governments, public health agencies,...